等待开盘 09-20 09:30:00 美东时间
+10.430
+54.69%
北京时间2024年09月20日03时16分,美国OTC市场Advaxis, Inc.(ADXS.us)股票出现波动,股价急速拉升5.00%。截至发稿,该股报0...
今天 03:16
GLMD: 60% | Galmed Pharmaceuticals Plans To Broaden Its Drug Development Activities, Consisting Of Two Additional Programs Over The Next Two Years EWTX: 42% | Edgewise Therapeutics Announced Top-line Data
09-19 20:06
Shares of Edgewise Therapeutics (NASDAQ:EWTX) climbed ~26% in the premarket on Thursday after the company, backed by topline results from Phase 1 and Phase 2 trials, announced plans to develop its hea...
09-19 19:25
Shares of Edgewise Therapeutics (NASDAQ:EWTX) added ~10% on Tuesday after Piper Sandler cited a potential catalyst related to the company’s experimental heart disease therapy, EDG-7500. EDG-7500, an o...
09-18 03:28
Shares of Dyne Therapeutics (NASDAQ:DYN) fell 31% Tuesday after the company released new data from a clinical trial called DELIVER for its drug DYNE-251 in the treatment of Duchenne muscular dystrophy...
09-04 04:48
Edgewise Therapeutics (EWTX) has provided an announcement. Edgewise Therapeutic...
08-13 05:29
JP Morgan analyst Tessa Romero maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Overweight and raises the price target from $30 to $31.
08-12 22:12
Edgewise Therapeutics Inc : JP Morgan Raises Target Price to $31 From $30
08-12 12:33
Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent ...
08-08 20:01
Edgewise Therapeutics Q2 Operating Income USD -38.107 Million
08-08 20:00